SCHEMBL28851825

SCHEMBL28851825

CCNc1ccccc1-c1cc(O)ccc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ IDO1 P14902 3/20 0.50
▸ CNR1 P21554 1/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ ESR2 Q92731 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ HPGD P15428 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ USP2 O75604 1/20 0.37
▸ CASP1 P29466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1168220 0.81 IDO1 (0.52) CYP3A4TSHRRECQLIDO1MEN1
SCHEMBL18415207 0.79 SMN1; SMN2 (0.46) CYP3A4TSHRRECQLIDO1MEN1
Methoxymethane SCHEMBL11831198 0.77 CYP3A4 (0.61) CYP3A4TSHRRECQLIDO1MEN1
SCHEMBL9191849 0.75 MAPK1 (0.55) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL28851826 0.75 IDO1 (0.49) CYP3A4TSHRRECQLIDO1MEN1
SCHEMBL8926002 0.75 ANPEP (0.47) CNR1CNR2ESR2KDM6BKDM6A
SCHEMBL4636219 0.75 ESR2 (0.55) CYP3A4RECQLMEN1KMT2AMAPT
SCHEMBL28278780 0.74 CYP3A4 (0.62) CYP3A4TSHRRECQLIDO1MEN1
SCHEMBL1368372 0.73 IDO1 (0.59) CYP3A4TSHRRECQLIDO1MEN1
SCHEMBL1163819 0.72 HPGD (0.49) CYP3A4TSHRMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114957357-A Aminoglycoside derivatives and their use in the treatment of genetic disorders ELOXX制药有限公司 2022-08-30 — — CN disclosed
Send feedback